HydroMARK Breast Biopsy Marker, Model No. 4010-05-08-T4 — FDA record Z-1124-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Mar 30, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
HydroMARK Breast Biopsy Marker, Model No. 4010-05-08-T4
Reason
Small patient labels do not match the primary device label. The primary device label accurately identifies the product as 4010-05-08-T4, while the smaller patient label incorrectly identifies the product as 4010-05-08-T3.
Classification
Class II
Recalling firm
Devicor Medical Products Inc
Quantity
90 devices
Agency-reported status
Terminated
Source record identifier
Z-1124-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI-DI: 00841911102472 Lot F12201281D

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Nationwide distribution in the states of DE, KY, NY, OH, WV.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Jun 1, 2022
Recall initiation date
Mar 30, 2022
Center classification date
May 23, 2022
Termination date
Apr 30, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records